Literature DB >> 6296016

Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition.

A L Barry, R N Jones, C Thornsberry, P C Fuchs, E H Gerlach, H M Sommers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296016     DOI: 10.1093/jac/10.suppl_c.25

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

Review 2.  Bacterial antibiotic resistance before and after clinical application in the United States.

Authors:  A L Barry; R N Jones
Journal:  Bull N Y Acad Med       Date:  1987-04

Review 3.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.

Authors:  A Sánchez-Navarro; C I Colino; M M Sánchez Recio
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

6.  Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae.

Authors:  M S Barrett; R N Jones; M E Erwin
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

7.  Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.

Authors:  K E Aldridge; C V Sanders; A Janney; S Faro; R L Marier
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 8.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.